MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Validation of MDS-UPDRS-based score to predict conversion to freezing of gait in Parkinson’s disease

N. D'Cruz, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)
Validation of previous empirical studies on the effect of Argentine Tango on the geriatric population with and without neurodegenerative disease

S. Peter, N. Crock, K. Carey, L. Johnson, A. Harbour, J. VanWart, S. Cofer, A. Eidenberger, R. Golan, K. Pique, C. Maitland (Tallahassee, FL, USA)
Value of nocturnal hypokinesia screening concerning the quality of life and clinical features in Parkinson’s disease

J. Choi, J. Lee, C. Shin, D. Yoo, J. Im, K. Woo, H. Kim, T. Ahn, J. Kim, B. Jeon (Seoul, Republic of Korea)
Varenicline for the Treatment of Postural and Gait Dysfunction in Parkinson’s Disease

D. Hall, S. Kapur, C. Vaughan, J. Hawkins, G. Stebbins (Chicago, IL, USA)
Variants in the saposin D domain of prosaposin gene are linked to Parkinson’s disease

Y. Oji, T. Hatano, S. Ueno, M. Funayama, K. Ishikawa, A. Okuzumi, S. Noda, S. Sato, W. Satake, T. Toda, Y. Li, T. Hino-Takai, S. Kakuta, T. Tsunemi, H. Yoshino, K. Nishioka, T. Hattori, Y. Mizutani, T. Mutoh, F. Yokochi, Y. Ichinose, K. Koh, K. Shindo, Y. Takiyama, T. Hamaguchi, M. Yamada, M. Farrer, Y. Uchiyama, W. Akamatsu, J. Matsuda, Y. Wu, N. Hattori (Tokyo, Japan)
Vascular age calculated by pulse wave velocity may help predict the prognosis after Deep brain stimulation surgery in patients with Parkinson’s disease

N. Naoko, K. Matsuura, A. Shindou, H. Kajikawa, T. Araki, H. Tomimoto (Tsu, mie, Japan)
Vascular factors in Parkinson’s disease with cognitive impairment

H.L Wang, YY. Gao, L.J Wang (Guangzhou, China)
Vascular Parkinsonism (VP) score: A clinical scoring system to differentiate between vascular from degenerative parkinsonism

M.I Acharya (Kolkata, India)
Vascular parkinsonism and Parkinson’s disease: Differences concerning performance in activities of daily living

R. Jesus, R. Raimundo, A. Marques, C. Azoia, M. Mendes, A. Velon (Vila Real, Portugal)
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus

Q. Wang (Guangzhou, China)
Vertically-Stacked Single Segment Activation (VSSA) as a Programming Approach for Directional DBS in Globus Pallidus Internus (GPi) in Parkinson’s Disease (PD) Patients: First Clinical Case Series

M. Anjum, Y. Torres-Yaghi, C. Kalhorn, F. Amjad, A. Carwin, I. Fayed, S. Pallavaram, D. Zhang, F. Pagan (Washington, DC, USA)
Video-based computer vision system exhibits concurrent validity with clinical ratings of head tremor severity in cervical dystonia

J. Vu, L. Le, X. Guo, R. Rouzbehani, D. Sy, R. Elble, G. Stebbins, C. Comella, D. Peterson (La Jolla, CA, USA)
Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial

R. Dobkin, S. Mann, K. Rodriguez, L. St. Hill, R. Miller, A. King, M. Gara, A. Interian (Piscataway, NJ, USA)
Virtual Assessment of LRRK2 Carriers to Optimize Research in Parkinson Disease (VALOR-PD): A Comparison to Traditional Cohorts

S. Jensen-Roberts, T. Myers, K. Amodeo, S. Sharma, R. Alcalay, E. Dorsey, R. Holloway, R. Schneider (Rochester, NY, USA)
Visual cortex involvement in the familial cortical myoclonic tremor with epilepsy type 1: a resting state-fMRI with regional homogeneity analysis

B. Wang, H.T Wang, Z.D Chen, W. Luo (Hangzhou, China)
Visual Hallucinations and Illusions in Parkinson’s Disease: The Role of Ocular Pathology

A. Marques, S. Beze, B. Pereira, C. Chassain, N. Monneyron, L. Delaby, C. Lambert, P. Derost, B. Debilly, I. Rieu, S.G Lewis, F. Chiambaretta, F. Durif (Clermont-Ferrand, France)
Visual Motion Perception and Metacognition in Parkinson’s disease

O. Halperin, R. Karni, S. Israeli-Korn, S. Hassin-Baer, A. Zaidel (Ramat Gan, Israel)
Visualization of Nigrosome 1 at 3T MRI and 18F-DOPA PET for the diagnosis of Parkinson´s disease

A. Martin-Bastida, V. Suarez-Vega, P. Dominguez-Echavarri, F. Guillen-Valderrama, I. Aviles-Olmos, J. Arbizu, M. Rodriguez-Oroz (Pamplona, Spain)
Visuomotor reaction time can predict IQ in children

S. Kiselev (Ekaterinburg, Russian Federation)
Visuospatial training improved the visuospatial abilities in child with cerebral palsy: case report

S. Kiselev (Ekaterinburg, Russian Federation)
Vitamin D assessment in patents with Parkinson’s disease

N.A Mansurova, Y.N Madjidova (Tashkent, Uzbekistan)
Vitamin Deficiencies in Parkinson’s Disease: A Case for Routine Screening

E. Smith, J. Paseka, D. Torres-Russotto, D. Bhatti, J. Bertoni (Omaha, NE, USA)
VMAT 2 inhibitor and Antipsychotic use in Individuals with Huntington’s Disease

E. Furr Stimming, L. Zhu, N. Pessoa Rocha (Houston, TX, USA)
Voltage Adjustment Effects More on Limb Symptoms than Axial Symptoms in Parkinson’s Disease Patients Treated with Subthalamic Nucleus Stimulation

W. Xian, L. Chen, J. Liu, C. Yang (Guangzhou, China)

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z